Prevention of Periprosthetic Bone Loss After Total Hip Replacement by Annual Bisphosphonate Therapy

Clinical trial NCT02838121 · COMPLETED

Trial details

NCT number: NCT02838121
Sponsor: Mel Shiuann-Sheng Lee
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prevention of BMD Loss After THR Serum Markers of Bone Turnover Functional Outcomes

Start date: 2009-12-01
Primary completion: 2013-01-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.